Boxer Capital, LLC
Related Filers (72)
- Boxer Asset Management Inc. (62)
- LEWIS JOSEPH (62)
- Mirati Therapeutics, Inc. (44)
- MVA Investors, LLC (39)
- Davis Aaron I. (24)
- Odonate Therapeutics, Inc. (17)
- ARADIGM CORP (12)
- iTeos Therapeutics, Inc. (10)
- Braslyn Ltd. (9)
- Solid Biosciences Inc. (9)
- Tango Therapeutics, Inc. (9)
- Rain Oncology Inc. (8)
- Somaxon Pharmaceuticals, Inc. (7)
- SOPHIRIS BIO INC. (7)
- Tyra Biosciences, Inc. (7)
- Fuglesang Christopher (7)
- Dissanayake Shehan Bharatha (7)
- Eleven Biotherapeutics, Inc. (6)
- DBV Technologies S.A. (6)
- PMV Pharmaceuticals, Inc. (6)
- LA JOLLA PHARMACEUTICAL CO (5)
- ONCOGENEX PHARMACEUTICALS, INC. (5)
- LIEBERBURG IVAN M (5)
- Berkley Capital Management Ltd. (5)
- Esperion Therapeutics, Inc. (5)
- MEDICINES CO /DE (5)
- Matinas BioPharma Holdings, Inc. (5)
- AMARIN CORP PLC\UK (4)
- Alexza Pharmaceuticals Inc. (4)
- GENTA INC DE/ (4)
- MACROGENICS INC (4)
- Atreca, Inc. (4)
- Milestone Pharmaceuticals Inc. (4)
- Mereo Biopharma Group plc (4)
- Cabaletta Bio, Inc. (4)
- AP PHARMA INC /DE/ (3)
- ROCKET PHARMACEUTICALS, INC. (3)
- PTC THERAPEUTICS, INC. (3)
- ESPERION THERAPEUTICS INC/MI (3)
- Wave Life Sciences Ltd. (3)
- Pandion Therapeutics, Inc. (3)
- Revolution Medicines, Inc. (3)
- Silverback Therapeutics, Inc. (3)
- IDEAYA Biosciences, Inc. (3)
- Akari Therapeutics Plc (2)
- Eiger BioPharmaceuticals, Inc. (2)
- Bellerophon Therapeutics, Inc. (2)
- LAPPE RODNEY W (2)
- Reisman Neil (2)
- Viking Therapeutics, Inc. (2)
- GTX INC /DE/ (2)
- SUNESIS PHARMACEUTICALS INC (2)
- BELLICUM PHARMACEUTICALS, INC (2)
- Trillium Therapeutics Inc. (2)
- POINT Biopharma Global Inc. (2)
- Cellectar Biosciences, Inc. (2)
- Syndax Pharmaceuticals Inc (2)
- Arcus Biosciences, Inc. (2)
- Biomea Fusion, Inc. (2)
- F-star Therapeutics, Inc. (2)
- MARINUS PHARMACEUTICALS INC (2)
- Talis Biomedical Corp (2)
- Elevation Oncology, Inc. (2)
- CymaBay Therapeutics, Inc. (2)
- Merus N.V. (2)
- RIGEL PHARMACEUTICALS INC (1)
- Tuesday Thirteen Inc. (1)
- Black Diamond Therapeutics, Inc. (1)
- SpringWorks Therapeutics, Inc. (1)
- Nkarta, Inc. (1)
- Lockend Five, LLC (1)
- FATE THERAPEUTICS INC (1)
- Show More ...
Other (38)
13F-HR
Wednesday, 2/14/2024
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Tuesday, 11/14/2023
Initial Quarterly Form 13F Holdings Report filed by institutional managers
144
Tuesday, 10/10/2023
Filing for proposed sale of securities under Rule 144
144
Wednesday, 8/23/2023
Filing for proposed sale of securities under Rule 144
13F-HR
Monday, 8/14/2023
Initial Quarterly Form 13F Holdings Report filed by institutional managers
144
Monday, 5/22/2023
Filing for proposed sale of securities under Rule 144
13F-HR
Monday, 5/15/2023
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Tuesday, 2/14/2023
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Monday, 11/14/2022
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Monday, 8/15/2022
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Monday, 5/16/2022
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Monday, 2/14/2022
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Monday, 11/15/2021
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Monday, 8/16/2021
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Monday, 5/17/2021
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Tuesday, 2/16/2021
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR/A
Tuesday, 11/17/2020
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Monday, 11/16/2020
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Friday, 8/14/2020
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Friday, 5/15/2020
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Friday, 2/14/2020
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Thursday, 11/14/2019
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR/A
Thursday, 8/15/2019
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Wednesday, 8/14/2019
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Wednesday, 5/15/2019
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Thursday, 2/14/2019
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Wednesday, 11/14/2018
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Tuesday, 8/14/2018
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Tuesday, 5/15/2018
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Wednesday, 2/14/2018
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Tuesday, 11/14/2017
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Monday, 8/14/2017
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Monday, 5/15/2017
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Tuesday, 2/14/2017
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Monday, 11/14/2016
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Monday, 8/15/2016
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Monday, 5/16/2016
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Tuesday, 2/16/2016
Initial Quarterly Form 13F Holdings Report filed by institutional managers
Ownership (271)
SC 13G/A
Wednesday, 2/14/2024
PMV Pharmaceuticals, Inc.: Major Shareholders
SC 13G
Monday, 2/12/2024
FATE THERAPEUTICS INC: Major Shareholders
SC 13D/A
Thursday, 2/8/2024
Tyra Biosciences, Inc.: Major Shareholders
4
Thursday, 2/8/2024
Tyra Biosciences, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 1/25/2024
Mirati Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
SC 13D/A
Thursday, 1/25/2024
Mirati Therapeutics, Inc.: Major Shareholders
SC 13G
Thursday, 1/18/2024
Nkarta, Inc.: Major Shareholders
SC 13D/A
Monday, 12/18/2023
Rain Oncology Inc.: Major Shareholders
4/A
Tuesday, 10/17/2023
Tango Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 10/17/2023
Tango Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
SC 13D/A
Thursday, 10/12/2023
Mirati Therapeutics, Inc.: Major Shareholders
4
Wednesday, 10/11/2023
Tango Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4/A
Wednesday, 10/11/2023
Tango Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 8/25/2023
iTeos Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
SC 13D/A
Wednesday, 8/16/2023
Mirati Therapeutics, Inc.: Major Shareholders
4
Tuesday, 8/15/2023
Tango Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 8/15/2023
Mirati Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 8/15/2023
Mirati Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
SC 13D/A
Thursday, 5/25/2023
Rain Oncology Inc.: Major Shareholders
4
Wednesday, 5/24/2023
Rain Oncology Inc.: Statement of changes in beneficial ownership of securities
SC 13G/A
Tuesday, 2/14/2023
Milestone Pharmaceuticals Inc.: Major Shareholders
SC 13G/A
Tuesday, 2/14/2023
IDEAYA Biosciences, Inc.: Major Shareholders
SC 13G/A
Tuesday, 2/14/2023
PMV Pharmaceuticals, Inc.: Major Shareholders
SC 13D/A
Tuesday, 11/8/2022
Rain Therapeutics Inc.: Major Shareholders
4
Thursday, 10/13/2022
Tango Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 10/6/2022
Tango Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
SC 13G
Monday, 9/19/2022
SpringWorks Therapeutics, Inc.: Major Shareholders
SC 13D/A
Thursday, 6/16/2022
Tyra Biosciences, Inc.: Major Shareholders
SC 13D/A
Wednesday, 5/11/2022
iTeos Therapeutics, Inc.: Major Shareholders
SC 13D/A
Monday, 3/21/2022
iTeos Therapeutics, Inc.: Major Shareholders
4
Friday, 3/18/2022
iTeos Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
SC 13G/A
Monday, 2/14/2022
Biomea Fusion, Inc.: Major Shareholders
SC 13G/A
Monday, 2/14/2022
Atreca, Inc.: Major Shareholders
SC 13G/A
Monday, 2/14/2022
MARINUS PHARMACEUTICALS INC: Major Shareholders
SC 13G/A
Monday, 2/14/2022
Cabaletta Bio, Inc.: Major Shareholders
SC 13G/A
Monday, 2/14/2022
Matinas BioPharma Holdings, Inc.: Major Shareholders
SC 13G/A
Monday, 2/14/2022
Merus N.V.: Major Shareholders
SC 13G/A
Monday, 2/14/2022
Mereo Biopharma Group plc: Major Shareholders
SC 13G/A
Monday, 2/14/2022
Elevation Oncology, Inc.: Major Shareholders
SC 13G/A
Monday, 2/14/2022
Milestone Pharmaceuticals Inc.: Major Shareholders
SC 13G/A
Monday, 2/14/2022
Silverback Therapeutics, Inc.: Major Shareholders
SC 13G/A
Monday, 2/14/2022
PMV Pharmaceuticals, Inc.: Major Shareholders
SC 13G/A
Monday, 2/14/2022
Talis Biomedical Corp: Major Shareholders
SC 13G/A
Monday, 2/14/2022
DBV Technologies S.A.: Major Shareholders
SC 13G/A
Monday, 2/14/2022
Solid Biosciences Inc.: Major Shareholders
SC 13G/A
Monday, 2/14/2022
CymaBay Therapeutics, Inc.: Major Shareholders
SC 13G/A
Monday, 2/14/2022
F-star Therapeutics, Inc.: Major Shareholders
SC 13G/A
Monday, 2/14/2022
POINT Biopharma Global Inc.: Major Shareholders
SC 13D/A
Thursday, 1/6/2022
iTeos Therapeutics, Inc.: Major Shareholders
4
Wednesday, 1/5/2022
iTeos Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 12/21/2021
Tyra Biosciences, Inc.: Statement of changes in beneficial ownership of securities
SC 13D/A
Friday, 11/26/2021
Odonate Therapeutics, Inc.: Major Shareholders
4
Wednesday, 11/24/2021
Odonate Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
SC 13D/A
Monday, 11/22/2021
Odonate Therapeutics, Inc.: Major Shareholders
4
Friday, 11/19/2021
Odonate Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
SC 13D
Friday, 9/24/2021
Tyra Biosciences, Inc.: Major Shareholders
4
Friday, 9/17/2021
Tyra Biosciences, Inc.: Statement of changes in beneficial ownership of securities
3
Tuesday, 9/14/2021
Tyra Biosciences, Inc.: Initial statement of beneficial ownership of securities
3
Friday, 8/20/2021
Tango Therapeutics, Inc.: Initial statement of beneficial ownership of securities
SC 13G
Friday, 7/9/2021
Elevation Oncology, Inc.: Major Shareholders
SC 13G
Monday, 5/17/2021
F-star Therapeutics, Inc.: Major Shareholders
SC 13D
Monday, 5/3/2021
Rain Therapeutics Inc.: Major Shareholders
SC 13G
Friday, 4/30/2021
Biomea Fusion, Inc.: Major Shareholders
4
Tuesday, 4/27/2021
Rain Therapeutics Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 4/22/2021
Rain Therapeutics Inc.: Initial statement of beneficial ownership of securities
4
Tuesday, 3/9/2021
Mirati Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
SC 13G
Friday, 2/26/2021
Talis Biomedical Corp: Major Shareholders
SC 13G/A
Tuesday, 2/16/2021
Cabaletta Bio, Inc.: Major Shareholders
SC 13G/A
Tuesday, 2/16/2021
Solid Biosciences Inc.: Major Shareholders
SC 13G/A
Tuesday, 2/16/2021
Cellectar Biosciences, Inc.: Major Shareholders
SC 13G/A
Tuesday, 2/16/2021
Revolution Medicines, Inc.: Major Shareholders
SC 13G/A
Tuesday, 2/16/2021
DBV Technologies S.A.: Major Shareholders
SC 13G/A
Tuesday, 2/16/2021
BELLICUM PHARMACEUTICALS, INC: Major Shareholders
SC 13G/A
Tuesday, 2/16/2021
Mereo Biopharma Group plc: Major Shareholders
SC 13G/A
Tuesday, 2/16/2021
Arcus Biosciences, Inc.: Major Shareholders
SC 13G/A
Tuesday, 2/16/2021
Atreca, Inc.: Major Shareholders
SC 13G/A
Tuesday, 2/16/2021
Matinas BioPharma Holdings, Inc.: Major Shareholders
SC 13G/A
Tuesday, 2/16/2021
Trillium Therapeutics Inc.: Major Shareholders
SC 13G/A
Tuesday, 2/16/2021
Syndax Pharmaceuticals Inc: Major Shareholders
SC 13G/A
Tuesday, 2/16/2021
Milestone Pharmaceuticals Inc.: Major Shareholders
SC 13G
Wednesday, 1/20/2021
Merus N.V.: Major Shareholders
4
Wednesday, 12/30/2020
Odonate Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
SC 13G/A
Friday, 12/18/2020
Silverback Therapeutics, Inc.: Major Shareholders
SC 13G
Thursday, 12/17/2020
Silverback Therapeutics, Inc.: Major Shareholders
SC 13D/A
Monday, 11/2/2020
Mirati Therapeutics, Inc.: Major Shareholders
4
Friday, 10/30/2020
Mirati Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 9/30/2020
Odonate Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
SC 13G
Wednesday, 9/30/2020
PMV Pharmaceuticals, Inc.: Major Shareholders
4
Tuesday, 9/29/2020
PMV Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
SC 13G
Thursday, 9/24/2020
CymaBay Therapeutics, Inc.: Major Shareholders
3
Thursday, 9/24/2020
PMV Pharmaceuticals, Inc.: Initial statement of beneficial ownership of securities
4
Wednesday, 9/9/2020
Odonate Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
SC 13D/A
Tuesday, 9/1/2020
Odonate Therapeutics, Inc.: Major Shareholders
4
Tuesday, 9/1/2020
Odonate Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
SC 13D
Friday, 8/7/2020
iTeos Therapeutics, Inc.: Major Shareholders
SC 13G
Monday, 8/3/2020
Milestone Pharmaceuticals Inc.: Major Shareholders
SC 13D
Thursday, 7/30/2020
Pandion Therapeutics, Inc.: Major Shareholders
4
Wednesday, 7/29/2020
iTeos Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 7/23/2020
iTeos Therapeutics, Inc.: Initial statement of beneficial ownership of securities
4
Tuesday, 7/21/2020
Pandion Therapeutics, Inc.: Statement of changes in beneficial ownership of securities